← Back to All Filings

Twist Bio Officer Files to Sell $157K in Stock for Tax Purposes

Low SignificanceNovember 3, 2025 at 3:32:07 PM EST

Twist Bioscience Corp

$TWST144CIK: 0001581280

Subscribe to track TWST

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Twist Bio Officer Files to Sell $157K in Stock for Tax Purposes

Company: Twist Bioscience Corp (TWST) Form: 144 | Filed: 2025-11-03 Significance: Low

Insider: Leproust Emily M. Title: Not Specified | Relationship: Officer, Director

Transaction: • Type: Proposed Sale • Shares: 4,887 • Price: ~$32.08 • Value: $156,772 • Owned After: Not Disclosed

Key Insight: This is a routine "sell-to-cover" transaction to pay taxes on vested equity awards. It is not a discretionary sale and holds minimal informational value.

Market Context: The sale represents a negligible 0.008% of shares outstanding and 0.0079% of the company's market cap.

Comprehensive Analysis

SEC Filing Analysis: Twist Bioscience Corp (TWST)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer and director at Twist Bioscience has filed a notice of proposed sale for 4,887 shares, valued at approximately $157k. The filing's remarks indicate the sale is to cover tax obligations from vested equity, classifying it as a non-discretionary "sell-to-cover" transaction.
  • Market Impact: The transaction is immaterial relative to the company's market capitalization and public float, and is expected to have a neutral market impact.

Company Information

FieldValue
CompanyTwist Bioscience Corp
Ticker SymbolTWST
CIK0001581280
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameLeproust Emily M.
CIK0001753655
Title/PositionNot Specified
RelationshipOfficer, Director

Transaction Details

FieldValue
Form Type144
Transaction Date2025-11-03
Transaction CodeNot Applicable
Security TypeCommon Stock
Shares Involved4,887
Price Per Share~$32.08
Total Value$156,772.03
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$156,772.03
% of Market Cap0.0079%
Shares Transacted4,887
% of Shares Outstanding0.0081%
Post-Transaction OwnershipNot Disclosed
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market capitalization of $1.99 billion, this $157k transaction is negligible and represents a tiny fraction of the company's total valuation.
  • Transaction Significance: The sale constitutes less than 0.01% of both the market cap and shares outstanding, falling far below any threshold for significance. The nature of the sale (tax-related) further reduces its importance as an indicator of insider sentiment.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The sale is a pre-disclosed, non-discretionary action to cover tax liabilities. Such transactions are common and do not reflect an insider's outlook on the company's future performance.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The number of shares is too small to have a noticeable effect on daily trading volume.
  • Sentiment Indicator: Neutral. The market generally disregards automated sell-to-cover transactions.

Additional Context

Transaction Notes

  • Special Circumstances: The filing explicitly states, "Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution." This confirms the sale is for tax purposes and is not a discretionary trade.
Topics:#SECFiling#InsiderTrading#TWST#TwistBioscience#Form144#InsiderSell#StockMarket#Biotechnology

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.